Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REBOXETINE for Depression: Side Effects & Safety Data

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

There are 62 adverse event reports in the FDA FAERS database where REBOXETINE was used for Depression.

Most Reported Side Effects for REBOXETINE

Side Effect Reports % Deaths Hosp.
Hyperhidrosis 21 11.4% 0 0
Off label use 20 10.8% 0 1
Weight increased 18 9.7% 0 0
Tachycardia 17 9.2% 2 2
Confusional state 16 8.7% 2 9
Intentional overdose 16 8.7% 2 10
Nausea 16 8.7% 1 6
Drug ineffective 15 8.1% 0 9
Drug interaction 15 8.1% 0 5
Sleep disorder 15 8.1% 0 3
Alanine aminotransferase increased 14 7.6% 0 1
Depression 14 7.6% 0 4
Dizziness 14 7.6% 0 1
Oedema peripheral 14 7.6% 0 0
Therapeutic product effect incomplete 14 7.6% 0 0

Other Indications for REBOXETINE

Product used for unknown indication (64) Bipolar disorder (11) Antidepressant therapy (7) Major depression (6) Schizophrenia (6) Drug abuse (5) Schizoaffective disorder (5)

Other Drugs Used for Depression

SERTRALINE (14,497) VENLAFAXINE (11,868) DULOXETINE (11,681) ESKETAMINE (10,058) ESCITALOPRAM OXALATE (7,373) FLUOXETINE (7,035) BUPROPION (6,165) MIRTAZAPINE (6,021) CITALOPRAM HYDROBROMIDE (5,450) PAROXETINE (5,386)

Related Pages

REBOXETINE Full Profile All Depression Drugs REBOXETINE Demographics REBOXETINE Timeline